Pharmacologically active 1,3-bis[1-(2-heteroalkylthio)ethylamino

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546255, 546116, 546275, 546276, 546278, 546279, 546280, C07D21353, A61K 3144

Patent

active

042106524

ABSTRACT:
The compounds are C.sub.2 -C.sub.8 straight chain alkanes terminally substituted, symmetrically or unsymmetrically, by N-(N'-substituted guanidino), N-(N',N"-disubstituted guanidino), N-(N'-substituted thioureido), N-(nitromethylene amidino) or S-(N-substituted isothioureido)groups. Two compounds of the invention are 1,3-bis-[N'-(2-(3-methoxy-2-pyridylmethylthio)ethyl)guanidino]propane and 1-[N-(2-(3-methoxy-pyridylmethylthio)ethyl)guanidino]-3-[N'-2-(5-methyl-4- imidazolylmethylthio)ethyl)guanidino]propane. The compounds of this invention are inhibitors of H-2 histamine receptors.

REFERENCES:
patent: 3968227 (1976-07-01), Durant et al.
patent: 4013659 (1977-03-01), Durant et al.
patent: 4154838 (1979-05-01), Durant et al.
patent: 4156727 (1979-05-01), Durant et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmacologically active 1,3-bis[1-(2-heteroalkylthio)ethylamino does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmacologically active 1,3-bis[1-(2-heteroalkylthio)ethylamino, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active 1,3-bis[1-(2-heteroalkylthio)ethylamino will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-298475

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.